Literature DB >> 29198772

Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination.

Tanya L Kowalczyk Mullins1, Susan L Rosenthal2, Gregory D Zimet3, Lili Ding4, Charlene Morrow5, Bin Huang4, Jessica A Kahn6.   

Abstract

PURPOSE: We examined longitudinally the relationship between human papillomavirus (HPV) vaccine-related risk perceptions and initiation of sexual activity among adolescent women over 30 months after HPV vaccination.
METHODS: Participants included 91 sexually inexperienced women aged 13-21 years receiving the HPV vaccine who completed at least three of five study visits. At every visit, participants completed surveys assessing HPV vaccine-related risk perceptions (perceived risk of sexually transmitted infections [STIs] other than HPV, perceived need for safer sexual behaviors), and sexual initiation. Outcomes were sexual initiation and age of sexual initiation. Associations between risk perceptions and outcomes were examined using ordered logistic regression models for sexual initiation and interval censored survival analyses for age of sexual initiation.
RESULTS: Mean age at baseline was 14.9 years (standard deviation [SD] 1.4). Most participants perceived themselves to be at risk of STIs other than HPV (mean scale score = 4.0/10; SD 2.1) and perceived a need for safer sexual behaviors (mean scale score = 1.5/10; SD 1.5). By 30 months, 65 participants (78%) initiated sex. Perceived risk of STIs and perceived need for safer sexual behaviors were not associated with sexual initiation or age of sexual initiation. Older age at baseline was associated with sooner sexual initiation (p = .02) and older age at sexual initiation (p < .001). Results of ordered logistic regression and survival analyses were unchanged when controlling for baseline age.
CONCLUSIONS: HPV vaccine-related risk perceptions were not associated with sexual initiation or age of sexual initiation, providing further support that HPV vaccine-related risk perceptions are unlikely to lead to riskier sexual behaviors.
Copyright © 2017 The Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; Human papillomavirus vaccines; Longitudinal study; Sexual behavior; Survey study

Mesh:

Substances:

Year:  2017        PMID: 29198772      PMCID: PMC5803391          DOI: 10.1016/j.jadohealth.2017.09.008

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  28 in total

1.  Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England.

Authors:  Alice S Forster; Laura A V Marlow; Judith Stephenson; Jane Wardle; Jo Waller
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

2.  Pediatric provider vaccine hesitancy: An under-recognized obstacle to immunizing children.

Authors:  Manika Suryadevara; Andrew Handel; Cynthia A Bonville; Donald A Cibula; Joseph B Domachowske
Journal:  Vaccine       Date:  2015-11-01       Impact factor: 3.641

3.  Risk homeostasis theory: an overview.

Authors:  G J Wilde
Journal:  Inj Prev       Date:  1998-06       Impact factor: 2.399

4.  Human papillomavirus vaccination and sexual behavior in young women.

Authors:  Mary B Rysavy; Jessica D K Kresowik; Dawei Liu; Lindsay Mains; Megan Lessard; Ginny L Ryan
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-01-07       Impact factor: 1.814

5.  Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination.

Authors:  Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Marcia Shew; J Dennis Fortenberry; David I Bernstein; Jessica A Kahn
Journal:  Arch Pediatr Adolesc Med       Date:  2012-01

6.  Human papillomavirus vaccine and behavioural disinhibition.

Authors:  Christine L Schuler; Paul L Reiter; Jennifer S Smith; Noel T Brewer
Journal:  Sex Transm Infect       Date:  2011-02-25       Impact factor: 3.519

7.  Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012.

Authors:  Eileen F Dunne; Shannon Stokley; Weiwei Chen; Fangjun Zhou
Journal:  J Adolesc Health       Date:  2015-04       Impact factor: 5.012

8.  Sexual experiences in relation to HPV vaccination status in female high school students in Sweden.

Authors:  Magdalena Mattebo; Nathalie Grün; Andreas Rosenblad; Margareta Larsson; Elisabet Häggström-Nordin; Tina Dalianis; Tanja Tydén
Journal:  Eur J Contracept Reprod Health Care       Date:  2014-02-20       Impact factor: 1.848

9.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; James A Singleton
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

10.  A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study.

Authors:  L Brabin; S A Roberts; R Stretch; D Baxter; P Elton; H Kitchener; R McCann
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more
  3 in total

Review 1.  Human Papillomavirus Vaccines: Successes and Future Challenges.

Authors:  Samara Perez; Gregory D Zimet; Ovidiu Tatar; Nathan W Stupiansky; William A Fisher; Zeev Rosberger
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

2.  Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.

Authors:  Chantal Sauvageau; Vladimir Gilca; Manale Ouakki; Marilou Kiely; François Coutlée; Sara Mathieu-Chartier; Fannie Defay; Gilles Lambert
Journal:  Hum Vaccin Immunother       Date:  2021-08-19       Impact factor: 4.526

3.  Adolescent HPV vaccination: empowerment, equity and ethics.

Authors:  Neisha Sundaram; Teck Chuan Voo; Clarence C Tam
Journal:  Hum Vaccin Immunother       Date:  2019-12-20       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.